FR2081464A1 - - Google Patents

Info

Publication number
FR2081464A1
FR2081464A1 FR7102796A FR7102796A FR2081464A1 FR 2081464 A1 FR2081464 A1 FR 2081464A1 FR 7102796 A FR7102796 A FR 7102796A FR 7102796 A FR7102796 A FR 7102796A FR 2081464 A1 FR2081464 A1 FR 2081464A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7102796A
Other languages
French (fr)
Other versions
FR2081464B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19702003714 external-priority patent/DE2003714C/de
Priority claimed from DE19702058086 external-priority patent/DE2058086A1/de
Priority claimed from DE19702058085 external-priority patent/DE2058085A1/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of FR2081464A1 publication Critical patent/FR2081464A1/fr
Application granted granted Critical
Publication of FR2081464B1 publication Critical patent/FR2081464B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR7102796A 1970-01-28 1971-01-28 Expired FR2081464B1 (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19702003714 DE2003714C (de) 1970-01-28 2 Piperazino 4 morpholino thieno eckige Klammer auf 3,2 d eckige Klammer zu pyrimidin und dessen Saureadditions salze
DE19702058086 DE2058086A1 (de) 1970-11-26 1970-11-26 Neue 4-Morpholino-thieno[3,2-d]pyrimidine,deren Salze und Verfahren zur Herstellung
DE19702058085 DE2058085A1 (de) 1970-11-26 1970-11-26 Neues Verfahren zur Herstellung von 4-Morpholino-thieno[3,2-d]pyrimidinen

Publications (2)

Publication Number Publication Date
FR2081464A1 true FR2081464A1 (enExample) 1971-12-03
FR2081464B1 FR2081464B1 (enExample) 1975-04-18

Family

ID=27182372

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7102796A Expired FR2081464B1 (enExample) 1970-01-28 1971-01-28

Country Status (9)

Country Link
US (1) US3763156A (enExample)
AU (1) AU2468871A (enExample)
BE (1) BE762135A (enExample)
ES (2) ES387554A1 (enExample)
FR (1) FR2081464B1 (enExample)
GB (1) GB1309182A (enExample)
IL (1) IL36079A0 (enExample)
NL (1) NL7101043A (enExample)
NO (1) NO129205B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570494A (en) * 1975-11-28 1980-07-02 Ici Ltd Thienopyrimidine derivatives and their use as pesticides
GB8912335D0 (en) * 1989-05-30 1989-07-12 Smithkline Beckman Intercredit Compounds
US5280026A (en) * 1989-05-30 1994-01-18 Smithkline Beecham Intercredit B.V. Thienopyrimidines
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
GB0423653D0 (en) * 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
ES2328400T3 (es) * 2005-04-21 2009-11-12 Boehringer Ingelheim International Gmbh Dihidrotienopirimidinas para el tratamiento de enfermedades inflamatorias.
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
BRPI0710874A2 (pt) 2006-04-26 2012-02-14 Hoffmann La Roche compostos de tienopirimidina, processos de produção dos referidos compostos, composições farmacêuticas contendo os mesmos, kit, produto, e usos dos compostos
CA2650295C (en) 2006-04-26 2015-12-29 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
AU2007243457B2 (en) 2006-04-26 2012-02-23 F. Hoffmann-La Roche Ag Pharmaceutical compounds
BRPI0717923A2 (pt) * 2006-12-07 2013-10-22 Genentech In '' composto, composição farmacêutica, método para tratar um câncer, processo para a produção de uma composição farmacêutica, usos, métodos para inibir ou modular a atividade da lipídeo quinase e kit ' '
TW200829594A (en) * 2006-12-07 2008-07-16 Piramed Ltd Phosphoinositide 3-kinase inhibitor compounds and methods of use
CA2704711C (en) 2007-09-24 2016-07-05 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
ATE537175T1 (de) 2007-10-19 2011-12-15 Boehringer Ingelheim Int Neue piperazino-dihydrothienopyrimidin-derivate
US8637519B2 (en) * 2007-10-19 2014-01-28 Boehringer Ingelheim International Gmbh Heterocycle-substituted piperazino-dihydrothienopyrimidines
EP2215092B1 (de) * 2007-10-19 2012-01-25 Boehringer Ingelheim International GmbH Substituierte piperidino-dihydrothienopyrimidine
JP5348725B2 (ja) * 2007-10-25 2013-11-20 ジェネンテック, インコーポレイテッド チエノピリミジン化合物の製造方法
GB0721095D0 (en) * 2007-10-26 2007-12-05 Piramed Ltd Pharmaceutical compounds
AU2010224125B2 (en) 2009-03-12 2015-05-14 Genentech, Inc. Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
SG175708A1 (en) 2009-05-27 2011-12-29 Genentech Inc Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
CA2772371A1 (en) * 2009-05-27 2010-12-02 F. Hoffmann-La Roche Ag Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
BR112012008483A2 (pt) * 2009-10-12 2019-09-24 Hoffmann La Roche combunações de um inibidor de pi3k e um inibidor de mex
EP2558864A1 (en) 2010-04-16 2013-02-20 Genentech, Inc. Fox03a as predictive biomarker for pi3k/akt kinase pathway inhibitor efficacy
US20140004209A1 (en) 2010-12-22 2014-01-02 Genentech, Inc. Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
AR094873A1 (es) 2013-02-25 2015-09-02 Genentech Inc Métodos y composiciones para detectar y tratar mutantes de akt resistentes a fármacos
US11098056B2 (en) * 2018-10-01 2021-08-24 Genzyme Corporation UDP glycosyltransferase inhibitors and methods of use
GB202014736D0 (en) * 2020-09-18 2020-11-04 Imperial College Innovations Ltd Novel compounds and their use in therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3475429A (en) * 1964-01-15 1969-10-28 Boehringer Sohn Ingelheim Thieno(3,2-d)pyrimidines and salts thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3475429A (en) * 1964-01-15 1969-10-28 Boehringer Sohn Ingelheim Thieno(3,2-d)pyrimidines and salts thereof

Also Published As

Publication number Publication date
ES387553A1 (es) 1974-01-16
FR2081464B1 (enExample) 1975-04-18
ES387554A1 (es) 1974-01-16
BE762135A (fr) 1971-07-27
IL36079A0 (en) 1971-03-24
US3763156A (en) 1973-10-02
AU2468871A (en) 1972-07-27
GB1309182A (en) 1973-03-07
NL7101043A (enExample) 1971-07-30
NO129205B (enExample) 1974-03-11

Similar Documents

Publication Publication Date Title
FR2081464B1 (enExample)
AU2044470A (enExample)
AU1473870A (enExample)
AU1517670A (enExample)
AU2017870A (enExample)
AU2130570A (enExample)
AU1326870A (enExample)
AU1716970A (enExample)
AU2085370A (enExample)
AU1833270A (enExample)
AU1336970A (enExample)
AU1581370A (enExample)
AU1832970A (enExample)
AU1603270A (enExample)
AU1591370A (enExample)
AU6979874A (enExample)
AU1918570A (enExample)
AU2061170A (enExample)
AU1789870A (enExample)
AU1343870A (enExample)
AU1689770A (enExample)
AU1841070A (enExample)
AU2115870A (enExample)
AU1328670A (enExample)
AU2112570A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse